The UK Health Security Agency (UKHSA) stated that cosmetic processes have recorded thirty -eight cases of botulism poisoning in England in the last six weeks after suspicious use of unlicensed botox.
Botulism is a rare but life-threatening condition caused by toxins produced by Clostridium botulinum bacteria, which is a major component in injection.
Cases have been registered in former, former Midlands and North east Area.
Ukhsa urged those who are demanding treatment to find evidence that their Botox businessmen were qualified and their products were licensed.
Botox injection is a common cosmetic process to reduce facial lines and wrinkles.
The product is made from small, pure doses of botulinum toxin, produced by the bacterial Clostridium botulinum. Large amounts of toxin can cause botulism.
According to the UKHSA, evidence so far suggests that clinics involved in cases have used products such as unlicensed botox.
In the most recent cases recorded in Eastern England and Eastern Midlands, patients had difficulty swallowing respiratory support, slad speech and difficulty.
Other symptoms of botulism may include dropped eyelids, double vision and weak facial muscles.
Dr. of Ukasa Gauri Godbol said that botulism related to beauty processes was rare but could be serious. He said that the symptoms could take up to four weeks to develop and anyone was urged that he suspected that he was suffering to contact NHS 111 service.
Botox can only be determined after a consultation between you and a healthcare professional, such as a doctor or nurse.
While the person signing the prescription does not need to be injected, they should ensure that the person injection is eligible to do so.
The Chief Security Officer of the Medicine and Healthcare Products Regulatory Agency, Dr. Alison Kev said: “Under any other circumstances, buying botulinum toxin increases the risk of getting a product, which is not a false or license for use in the UK.
“This means that there are no safety measures to ensure products to ensure that met MHRA standards for quality and safety.”
For cosmetic practitioners, the Joint Council says it receives several reports of “illegal supply and use of unlicensed botulinum toxins”.
This suggests that people considering botox injection seek information about the product before accepting a procedure, including its brands and intended doses.
People should again check these details with the person who carries out the process on their treatment day. The prescription for Botox should be in the name of the customer.
Ukhsa recommends the following precautions:
- Ensure that a businessman is eligible, wearing suitable protective equipment and washes his hands. Physicians should be happy to discuss their qualifications
- Those who seek a procedure must be offered a consultation in advance that covers the investigation for medical conditions
- A consent form underlining the risks should be discussed and signed.
